Autor:	AA Cohen, L. Luciani, C. Le Dissez, C Guilmet, G. de Pouvourville, K. Le Lay
Rok vydání:	2017
Předmět:	Risk analysis (engineering) Cost effectiveness Computer science Health Policy Public Health Environmental and Occupational Health medicine Dabigatran medicine.drug
Zdroj:	Value in Health. 20:A399
ISSN:	1098-3015
DOI:	10.1016/j.jval.2017.08.004
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::cce098cc368a26d3bffdfc3464b58774 https://doi.org/10.1016/j.jval.2017.08.004 Zobrazit plný text záznamu Full Text from ScienceDirect